The U.S. drugmaker pressed the scientific case for its controversial plan to acquire AstraZeneca.
Deal with Germany's Bayer AG adds to a string of major cross-border healthcare deals.
Pfizer's pursuit of AstraZeneca comes amid a wave of deal-making in the healthcare sector.
Would be one of the biggest in an already swelling series of deal efforts among drug makers.
One of the largest drugstore chain's in the U.S. announced it will no longer sell tobacco products at its 7,600 pharmacies by Oct. 1.
Preliminary takeover offer from Germany's Bayer AG values the company at about $2.4B.
Completes Pfizer's 2009 acquisition of rival Wyeth.
The Dutch chemicals maker will contribute its own drug manufacturing operations to the new company.
Net profit reached €733M, up from €516M in the same quarter a year ago.
French drug maker continued to suffer the effects of overpaying for acquisitions and a painful restructuring.
Copyright © 2017. All rights reserved.